Short term effects of levothyroxine treatment in thyroid multinodular disease

The levothyroxine suppressive efficacy in benign thyroid nodules treatment is well described in uninodular non-toxic goiter, whereas only few controlled trials enrolled patients with multinodular disease. The aim of the present study is to evaluate the short term effects of levothyroxine treatment i...

Full description

Saved in:
Bibliographic Details
Published in:ENDOCRINE JOURNAL 2010, Vol.57(9), pp.803-809
Main Authors: Cesareo, Roberto, Iozzino, Mario, Isgrò, Maria Antonietta, Annunziata, Francesca, Stasio, Enrico Di
Format: Article
Language:English
Subjects:
Adult
Female
Goiter, Nodular - diagnostic imaging
Goiter, Nodular - drug therapy
Goiter, Nodular - pathology
Humans
Levothyroxine therapy
Middle Aged
Multinodular goiter
Pre-menopausal women
Premenopause
Thyroid
Thyroid Gland - diagnostic imaging
Thyroid Gland - pathology
Thyrotropin
Thyroxine - blood
Thyroxine - therapeutic use
Triiodothyronine - blood
Ultrasonography
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c658t-935f4ff78fa59f9b99e4cc793ff1dde3e8db542686b7dc82791623c6b07590d13
cites cdi_FETCH-LOGICAL-c658t-935f4ff78fa59f9b99e4cc793ff1dde3e8db542686b7dc82791623c6b07590d13
container_end_page 809
container_issue 9
container_start_page 803
container_title ENDOCRINE JOURNAL
container_volume 57
creator Cesareo, Roberto
Iozzino, Mario
Isgrò, Maria Antonietta
Annunziata, Francesca
Stasio, Enrico Di
description The levothyroxine suppressive efficacy in benign thyroid nodules treatment is well described in uninodular non-toxic goiter, whereas only few controlled trials enrolled patients with multinodular disease. The aim of the present study is to evaluate the short term effects of levothyroxine treatment in never treated, pre-menopausal women affected by thyroid multinodular disease. Seventy-one pre-menopausal women with thyroid multinodular disease, still presenting normal TSH levels, from Latina area were randomly assigned to a levothyroxine treated or control group. Biochemical and ultrasonography evaluations of thyroid were monitored at the enrolment and after 6, 12 and 24 months of treatment. In the levothyroxine treated group, after 1 year of treatment, thyroid and dominant nodule volume and number of nodules >0.5 mL significantly decreased from a median of 12.0 to 9.8 mL (p
doi_str_mv 10.1507/endocrj.K10E-144
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_756666541</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>756666541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c658t-935f4ff78fa59f9b99e4cc793ff1dde3e8db542686b7dc82791623c6b07590d13</originalsourceid><addsrcrecordid>eNo9kM1P3DAQxS3UChbae09Vbj2F2vH3sUJAUal6KJwtxx53s0pisJ2q_Pd12GV9mJHsN--Nfwh9IviScCy_wuyjS7vLHwRft4SxE7QhlKmWcYbfoQ3WRLVKc32GznPeYUwpZ_QUnXVYKEpkt0E_f29jKk2BNDUQAriSmxiaEf7Gsn1J8d8wQ1MS2DLBXJphbl6vB99My1iGOfpltKnxQwab4QN6H-yY4eOhX6DHm-uHq-_t_a_bu6tv960TXJVWUx5YCFIFy3XQvdbAnJOahkC8BwrK95x1Qoleeqc6qYnoqBM9llxjT-gF-rL3fUrxeYFczDRkB-NoZ4hLNpKLejhblXivdCnmnCCYpzRMNr0Ygs3K0BwYmpWhqQzryOeD-dJP4I8Db9Cq4HYvqK-Ds2Ocx0rJ7OKS5vpr457Fq2mdqCEYc4l1bdJghelaNKGCKbFG3eyddrnYP3CMsqkMboTjblwavZa3HY8Ct7Wpquh_NAif_g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>756666541</pqid></control><display><type>article</type><title>Short term effects of levothyroxine treatment in thyroid multinodular disease</title><source>J-STAGE Free Content</source><creator>Cesareo, Roberto ; Iozzino, Mario ; Isgrò, Maria Antonietta ; Annunziata, Francesca ; Stasio, Enrico Di</creator><creatorcontrib>Cesareo, Roberto ; Iozzino, Mario ; Isgrò, Maria Antonietta ; Annunziata, Francesca ; Stasio, Enrico Di ; Ospedale “S.M.Goretti” ; Institute of Biochemistry and Clinical Biochemistry ; Catholic University of Sacred Heart ; Thyroid Disease Ambulatory and Thyroid Echointervention ; Institute of Radiology Ospedale“S.M.Goretti”</creatorcontrib><description>The levothyroxine suppressive efficacy in benign thyroid nodules treatment is well described in uninodular non-toxic goiter, whereas only few controlled trials enrolled patients with multinodular disease. The aim of the present study is to evaluate the short term effects of levothyroxine treatment in never treated, pre-menopausal women affected by thyroid multinodular disease. Seventy-one pre-menopausal women with thyroid multinodular disease, still presenting normal TSH levels, from Latina area were randomly assigned to a levothyroxine treated or control group. Biochemical and ultrasonography evaluations of thyroid were monitored at the enrolment and after 6, 12 and 24 months of treatment. In the levothyroxine treated group, after 1 year of treatment, thyroid and dominant nodule volume and number of nodules &gt;0.5 mL significantly decreased from a median of 12.0 to 9.8 mL (p &lt;0.001), from 1.0 to 0.5 mL (p &lt;0.001) and from 0.5 to 0, respectively. Conversely, in the control group significant augmented values of these parameters were observed (p =0.007, p &lt;0.001 and p &lt;0.001, respectively). Furthermore, these observations were also confirmed by results obtained after a 24 months follow-up period. Our data support previous observations on the clinical usefulness of L-T4 treatment in preventing thyroid and nodule volume and nodule numbers growth. These findings confirm the tendency of benign nodular disease toward progression and the efficacy of TSH suppression in preventing its evolution by means of removing the major growth factor for thyroid nodules still responsive to physiological stimuli.</description><identifier>ISSN: 0918-8959</identifier><identifier>EISSN: 1348-4540</identifier><identifier>DOI: 10.1507/endocrj.K10E-144</identifier><identifier>PMID: 20683172</identifier><language>eng</language><publisher>Japan: The Japan Endocrine Society</publisher><subject>Adult ; Female ; Goiter, Nodular - diagnostic imaging ; Goiter, Nodular - drug therapy ; Goiter, Nodular - pathology ; Humans ; Levothyroxine therapy ; Middle Aged ; Multinodular goiter ; Pre-menopausal women ; Premenopause ; Thyroid ; Thyroid Gland - diagnostic imaging ; Thyroid Gland - pathology ; Thyrotropin ; Thyroxine - blood ; Thyroxine - therapeutic use ; Triiodothyronine - blood ; Ultrasonography</subject><ispartof>Endocrine Journal, 2010, Vol.57(9), pp.803-809</ispartof><rights>The Japan Endocrine Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c658t-935f4ff78fa59f9b99e4cc793ff1dde3e8db542686b7dc82791623c6b07590d13</citedby><cites>FETCH-LOGICAL-c658t-935f4ff78fa59f9b99e4cc793ff1dde3e8db542686b7dc82791623c6b07590d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1882,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20683172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cesareo, Roberto</creatorcontrib><creatorcontrib>Iozzino, Mario</creatorcontrib><creatorcontrib>Isgrò, Maria Antonietta</creatorcontrib><creatorcontrib>Annunziata, Francesca</creatorcontrib><creatorcontrib>Stasio, Enrico Di</creatorcontrib><creatorcontrib>Ospedale “S.M.Goretti”</creatorcontrib><creatorcontrib>Institute of Biochemistry and Clinical Biochemistry</creatorcontrib><creatorcontrib>Catholic University of Sacred Heart</creatorcontrib><creatorcontrib>Thyroid Disease Ambulatory and Thyroid Echointervention</creatorcontrib><creatorcontrib>Institute of Radiology Ospedale“S.M.Goretti”</creatorcontrib><title>Short term effects of levothyroxine treatment in thyroid multinodular disease</title><title>ENDOCRINE JOURNAL</title><addtitle>Endocr J</addtitle><description>The levothyroxine suppressive efficacy in benign thyroid nodules treatment is well described in uninodular non-toxic goiter, whereas only few controlled trials enrolled patients with multinodular disease. The aim of the present study is to evaluate the short term effects of levothyroxine treatment in never treated, pre-menopausal women affected by thyroid multinodular disease. Seventy-one pre-menopausal women with thyroid multinodular disease, still presenting normal TSH levels, from Latina area were randomly assigned to a levothyroxine treated or control group. Biochemical and ultrasonography evaluations of thyroid were monitored at the enrolment and after 6, 12 and 24 months of treatment. In the levothyroxine treated group, after 1 year of treatment, thyroid and dominant nodule volume and number of nodules &gt;0.5 mL significantly decreased from a median of 12.0 to 9.8 mL (p &lt;0.001), from 1.0 to 0.5 mL (p &lt;0.001) and from 0.5 to 0, respectively. Conversely, in the control group significant augmented values of these parameters were observed (p =0.007, p &lt;0.001 and p &lt;0.001, respectively). Furthermore, these observations were also confirmed by results obtained after a 24 months follow-up period. Our data support previous observations on the clinical usefulness of L-T4 treatment in preventing thyroid and nodule volume and nodule numbers growth. These findings confirm the tendency of benign nodular disease toward progression and the efficacy of TSH suppression in preventing its evolution by means of removing the major growth factor for thyroid nodules still responsive to physiological stimuli.</description><subject>Adult</subject><subject>Female</subject><subject>Goiter, Nodular - diagnostic imaging</subject><subject>Goiter, Nodular - drug therapy</subject><subject>Goiter, Nodular - pathology</subject><subject>Humans</subject><subject>Levothyroxine therapy</subject><subject>Middle Aged</subject><subject>Multinodular goiter</subject><subject>Pre-menopausal women</subject><subject>Premenopause</subject><subject>Thyroid</subject><subject>Thyroid Gland - diagnostic imaging</subject><subject>Thyroid Gland - pathology</subject><subject>Thyrotropin</subject><subject>Thyroxine - blood</subject><subject>Thyroxine - therapeutic use</subject><subject>Triiodothyronine - blood</subject><subject>Ultrasonography</subject><issn>0918-8959</issn><issn>1348-4540</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNo9kM1P3DAQxS3UChbae09Vbj2F2vH3sUJAUal6KJwtxx53s0pisJ2q_Pd12GV9mJHsN--Nfwh9IviScCy_wuyjS7vLHwRft4SxE7QhlKmWcYbfoQ3WRLVKc32GznPeYUwpZ_QUnXVYKEpkt0E_f29jKk2BNDUQAriSmxiaEf7Gsn1J8d8wQ1MS2DLBXJphbl6vB99My1iGOfpltKnxQwab4QN6H-yY4eOhX6DHm-uHq-_t_a_bu6tv960TXJVWUx5YCFIFy3XQvdbAnJOahkC8BwrK95x1Qoleeqc6qYnoqBM9llxjT-gF-rL3fUrxeYFczDRkB-NoZ4hLNpKLejhblXivdCnmnCCYpzRMNr0Ygs3K0BwYmpWhqQzryOeD-dJP4I8Db9Cq4HYvqK-Ds2Ocx0rJ7OKS5vpr457Fq2mdqCEYc4l1bdJghelaNKGCKbFG3eyddrnYP3CMsqkMboTjblwavZa3HY8Ct7Wpquh_NAif_g</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Cesareo, Roberto</creator><creator>Iozzino, Mario</creator><creator>Isgrò, Maria Antonietta</creator><creator>Annunziata, Francesca</creator><creator>Stasio, Enrico Di</creator><general>The Japan Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2010</creationdate><title>Short term effects of levothyroxine treatment in thyroid multinodular disease</title><author>Cesareo, Roberto ; Iozzino, Mario ; Isgrò, Maria Antonietta ; Annunziata, Francesca ; Stasio, Enrico Di</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c658t-935f4ff78fa59f9b99e4cc793ff1dde3e8db542686b7dc82791623c6b07590d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Female</topic><topic>Goiter, Nodular - diagnostic imaging</topic><topic>Goiter, Nodular - drug therapy</topic><topic>Goiter, Nodular - pathology</topic><topic>Humans</topic><topic>Levothyroxine therapy</topic><topic>Middle Aged</topic><topic>Multinodular goiter</topic><topic>Pre-menopausal women</topic><topic>Premenopause</topic><topic>Thyroid</topic><topic>Thyroid Gland - diagnostic imaging</topic><topic>Thyroid Gland - pathology</topic><topic>Thyrotropin</topic><topic>Thyroxine - blood</topic><topic>Thyroxine - therapeutic use</topic><topic>Triiodothyronine - blood</topic><topic>Ultrasonography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cesareo, Roberto</creatorcontrib><creatorcontrib>Iozzino, Mario</creatorcontrib><creatorcontrib>Isgrò, Maria Antonietta</creatorcontrib><creatorcontrib>Annunziata, Francesca</creatorcontrib><creatorcontrib>Stasio, Enrico Di</creatorcontrib><creatorcontrib>Ospedale “S.M.Goretti”</creatorcontrib><creatorcontrib>Institute of Biochemistry and Clinical Biochemistry</creatorcontrib><creatorcontrib>Catholic University of Sacred Heart</creatorcontrib><creatorcontrib>Thyroid Disease Ambulatory and Thyroid Echointervention</creatorcontrib><creatorcontrib>Institute of Radiology Ospedale“S.M.Goretti”</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ENDOCRINE JOURNAL</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cesareo, Roberto</au><au>Iozzino, Mario</au><au>Isgrò, Maria Antonietta</au><au>Annunziata, Francesca</au><au>Stasio, Enrico Di</au><aucorp>Ospedale “S.M.Goretti”</aucorp><aucorp>Institute of Biochemistry and Clinical Biochemistry</aucorp><aucorp>Catholic University of Sacred Heart</aucorp><aucorp>Thyroid Disease Ambulatory and Thyroid Echointervention</aucorp><aucorp>Institute of Radiology Ospedale“S.M.Goretti”</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Short term effects of levothyroxine treatment in thyroid multinodular disease</atitle><jtitle>ENDOCRINE JOURNAL</jtitle><addtitle>Endocr J</addtitle><date>2010</date><risdate>2010</risdate><volume>57</volume><issue>9</issue><spage>803</spage><epage>809</epage><pages>803-809</pages><issn>0918-8959</issn><eissn>1348-4540</eissn><abstract>The levothyroxine suppressive efficacy in benign thyroid nodules treatment is well described in uninodular non-toxic goiter, whereas only few controlled trials enrolled patients with multinodular disease. The aim of the present study is to evaluate the short term effects of levothyroxine treatment in never treated, pre-menopausal women affected by thyroid multinodular disease. Seventy-one pre-menopausal women with thyroid multinodular disease, still presenting normal TSH levels, from Latina area were randomly assigned to a levothyroxine treated or control group. Biochemical and ultrasonography evaluations of thyroid were monitored at the enrolment and after 6, 12 and 24 months of treatment. In the levothyroxine treated group, after 1 year of treatment, thyroid and dominant nodule volume and number of nodules &gt;0.5 mL significantly decreased from a median of 12.0 to 9.8 mL (p &lt;0.001), from 1.0 to 0.5 mL (p &lt;0.001) and from 0.5 to 0, respectively. Conversely, in the control group significant augmented values of these parameters were observed (p =0.007, p &lt;0.001 and p &lt;0.001, respectively). Furthermore, these observations were also confirmed by results obtained after a 24 months follow-up period. Our data support previous observations on the clinical usefulness of L-T4 treatment in preventing thyroid and nodule volume and nodule numbers growth. These findings confirm the tendency of benign nodular disease toward progression and the efficacy of TSH suppression in preventing its evolution by means of removing the major growth factor for thyroid nodules still responsive to physiological stimuli.</abstract><cop>Japan</cop><pub>The Japan Endocrine Society</pub><pmid>20683172</pmid><doi>10.1507/endocrj.K10E-144</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-8959
ispartof Endocrine Journal, 2010, Vol.57(9), pp.803-809
issn 0918-8959
1348-4540
language eng
recordid cdi_proquest_miscellaneous_756666541
source J-STAGE Free Content
subjects Adult
Female
Goiter, Nodular - diagnostic imaging
Goiter, Nodular - drug therapy
Goiter, Nodular - pathology
Humans
Levothyroxine therapy
Middle Aged
Multinodular goiter
Pre-menopausal women
Premenopause
Thyroid
Thyroid Gland - diagnostic imaging
Thyroid Gland - pathology
Thyrotropin
Thyroxine - blood
Thyroxine - therapeutic use
Triiodothyronine - blood
Ultrasonography
title Short term effects of levothyroxine treatment in thyroid multinodular disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T17%3A43%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Short%20term%20effects%20of%20levothyroxine%20treatment%20in%20thyroid%20multinodular%20disease&rft.jtitle=ENDOCRINE%20JOURNAL&rft.au=Cesareo,%20Roberto&rft.aucorp=Ospedale%20%E2%80%9CS.M.Goretti%E2%80%9D&rft.date=2010&rft.volume=57&rft.issue=9&rft.spage=803&rft.epage=809&rft.pages=803-809&rft.issn=0918-8959&rft.eissn=1348-4540&rft_id=info:doi/10.1507/endocrj.K10E-144&rft_dat=%3Cproquest_cross%3E756666541%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c658t-935f4ff78fa59f9b99e4cc793ff1dde3e8db542686b7dc82791623c6b07590d13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=756666541&rft_id=info:pmid/20683172&rfr_iscdi=true